BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 38424612)

  • 1. Automated segmentation of lesions and organs at risk on [
    Yazdani E; Karamzadeh-Ziarati N; Cheshmi SS; Sadeghi M; Geramifar P; Vosoughi H; Jahromi MK; Kheradpisheh SR
    Cancer Imaging; 2024 Feb; 24(1):30. PubMed ID: 38424612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSMA-Hornet: Fully-automated, multi-target segmentation of healthy organs in PSMA PET/CT images.
    Klyuzhin IS; Chaussé G; Bloise I; Harsini S; Ferres JL; Uribe C; Rahmim A
    Med Phys; 2024 Feb; 51(2):1203-1216. PubMed ID: 37544015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A convolutional neural network-based system for fully automatic segmentation of whole-body [
    Jafari E; Zarei A; Dadgar H; Keshavarz A; Manafi-Farid R; Rostami H; Assadi M
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1476-1487. PubMed ID: 38095671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic segmentation of prostate cancer metastases in PSMA PET/CT images using deep neural networks with weighted batch-wise dice loss.
    Xu Y; Klyuzhin I; Harsini S; Ortiz A; Zhang S; Bénard F; Dodhia R; Uribe CF; Rahmim A; Lavista Ferres J
    Comput Biol Med; 2023 May; 158():106882. PubMed ID: 37037147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning-based whole-body characterization of prostate cancer lesions on [
    Huang B; Yang Q; Li X; Wu Y; Liu Z; Pan Z; Zhong S; Song S; Zuo C
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1173-1184. PubMed ID: 38049657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [
    Kendrick J; Francis RJ; Hassan GM; Rowshanfarzad P; Ong JSL; Ebert MA
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):67-79. PubMed ID: 35976392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SwinCross: Cross-modal Swin transformer for head-and-neck tumor segmentation in PET/CT images.
    Li GY; Chen J; Jang SI; Gong K; Li Q
    Med Phys; 2024 Mar; 51(3):2096-2107. PubMed ID: 37776263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Translation and First In-Human Use of [
    Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
    Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Learning fuzzy clustering for SPECT/CT segmentation via convolutional neural networks.
    Chen J; Li Y; Luna LP; Chung HW; Rowe SP; Du Y; Solnes LB; Frey EC
    Med Phys; 2021 Jul; 48(7):3860-3877. PubMed ID: 33905560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body uptake classification and prostate cancer staging in
    Capobianco N; Sibille L; Chantadisai M; Gafita A; Langbein T; Platsch G; Solari EL; Shah V; Spottiswoode B; Eiber M; Weber WA; Navab N; Nekolla SG
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):517-526. PubMed ID: 34232350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [
    Johnsson K; Brynolfsson J; Sahlstedt H; Nickols NG; Rettig M; Probst S; Morris MJ; Bjartell A; Eiber M; Anand A
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1041-1051. PubMed ID: 34463809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early molecular imaging response assessment based on determination of total viable tumor burden in [
    Rosar F; Wenner F; Khreish F; Dewes S; Wagenpfeil G; Hoffmann MA; Schreckenberger M; Bartholomä M; Ezziddin S
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1584-1594. PubMed ID: 34725725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential privacy preserved federated transfer learning for multi-institutional
    Shiri I; Salimi Y; Maghsudi M; Jenabi E; Harsini S; Razeghi B; Mostafaei S; Hajianfar G; Sanaat A; Jafari E; Samimi R; Khateri M; Sheikhzadeh P; Geramifar P; Dadgar H; Bitrafan Rajabi A; Assadi M; Bénard F; Vafaei Sadr A; Voloshynovskiy S; Mainta I; Uribe C; Rahmim A; Zaidi H
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):40-53. PubMed ID: 37682303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
    Kostyszyn D; Fechter T; Bartl N; Grosu AL; Gratzke C; Sigle A; Mix M; Ruf J; Fassbender TF; Kiefer S; Bettermann AS; Nicolay NH; Spohn S; Kramer MU; Bronsert P; Guo H; Qiu X; Wang F; Henkenberens C; Werner RA; Baltas D; Meyer PT; Derlin T; Chen M; Zamboglou C
    J Nucl Med; 2021 Jun; 62(6):823-828. PubMed ID: 33127624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning-based prediction of invisible intraprostatic prostate cancer lesions on
    Yi Z; Hu S; Lin X; Zou Q; Zou M; Zhang Z; Xu L; Jiang N; Zhang Y
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1523-1534. PubMed ID: 34845536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Triple-Tracer strategy against Metastatic PrOstate cancer (3TMPO) study protocol.
    Pouliot F; Beauregard JM; Saad F; Trudel D; Richard PO; Turcotte É; Rousseau É; Probst S; Kassouf W; Anidjar M; Camirand Lemyre F; Bouvet GF; Neveu B; Tétu A; Guérin B
    BJU Int; 2022 Sep; 130(3):314-322. PubMed ID: 34674367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using
    Denis CS; Cousin F; Laere B; Hustinx R; Sautois BR; Withofs N
    J Nucl Med; 2022 Dec; 63(12):1815-1821. PubMed ID: 35450960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of uptake time on image quality of [
    van der Sar ECA; Viol SLM; Braat AJAT; van Rooij R; Lam MGEH; de Jong HWAM; de Keizer B
    Med Phys; 2023 Dec; 50(12):7619-7628. PubMed ID: 37093883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining Absorbed Doses of Indigenously Developed
    Kamaldeep ; Wanage G; Sahu SK; Maletha P; Adnan A; Suman S; Basu S; Das T; Banerjee S
    Cancer Biother Radiopharm; 2021 Apr; 36(3):292-304. PubMed ID: 32379495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.